Results 241 to 250 of about 16,833,685 (312)

TCRBinder: Unified pre-trained language model with paired-chain synergy for predicting T-cell receptor binding specificity. [PDF]

PLoS Comput Biol
Dong W, Yang Q, Xu L, Li X, Wang K, Dong S, Luo G, Zhang X, Yang T, Gao X, Wang G.   +10 more
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Identification of Sjögren's disease-associated T cell receptor motifs through deep sequencing. [PDF]

JCI Insight
Jupudi AA, Joachims ML, Lawrence C, Lopez-Davis C, Khatri B, Rasmussen A, Grundahl K, Scofield RH, James JA, Guthridge JM, Lessard CJ, Thompson LF, Farris AD.   +12 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

The canine T cell receptor repertoire. [PDF]

Immunohorizons
Allaway D, Harrison M, Pink C, Haydock R, Jayaprakash AD, Sachidanandam R.   +5 more
europepmc   +1 more source

T-cell receptor therapy in ovarian cancer: concepts and challenges. [PDF]

J Ovarian Res
Wang X, Li Z, Zhang M, Yu Y, Tong W.
europepmc   +1 more source

T-cell Receptor Profiling of Blood to Detect Lung Cancer. [PDF]

Cancer Immunol Res
Søgaard MT, Tseng D, Gibbs S, Wu W, Nolan LG, Yang PY, Lai M, Cao J, Pipavath S, Mayer-Blackwell K, Newell EW, Houghton AM, Payne KK, Chiou SH, Nair VS.   +14 more
europepmc   +1 more source

γδ T cell receptor recognition of CD1d in a lipid-independent manner. [PDF]

Nat Commun
Rice MT, Gunasinghe SD, Sok CL, Pan M, Lay CS, Gully BS, Rossjohn J.   +6 more
europepmc   +1 more source

Weak SLP-76/PLC-γ1 interaction fine-tunes T cell receptor signal strength to optimize T cell responsiveness. [PDF]

Nat Commun
Yamane H, Wada J, Stassenko EN, Convertino ND, Lee ME, Vacchio MS, Li W, Livak F, Rathnayake UM, Balagopalan L, Chari R, Hagenau H, Awasthi P, McGavern DB, Bosselut R, Samelson LE.   +15 more
europepmc   +1 more source